MY196709A - An anti-ovarian cancer composition - Google Patents

An anti-ovarian cancer composition

Info

Publication number
MY196709A
MY196709A MYUI2018702577A MYUI2018702577A MY196709A MY 196709 A MY196709 A MY 196709A MY UI2018702577 A MYUI2018702577 A MY UI2018702577A MY UI2018702577 A MYUI2018702577 A MY UI2018702577A MY 196709 A MY196709 A MY 196709A
Authority
MY
Malaysia
Prior art keywords
ovarian cancer
eurycomalactone
present innovation
cancer
cancer composition
Prior art date
Application number
MYUI2018702577A
Inventor
Murni Yunos Nurhanan
Haffiz Jauri Muhd
Mohd Shah Zamree
Original Assignee
Forest Res Institute Malaysia Frim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Res Institute Malaysia Frim filed Critical Forest Res Institute Malaysia Frim
Priority to MYUI2018702577A priority Critical patent/MY196709A/en
Publication of MY196709A publication Critical patent/MY196709A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An anti-ovarian cancer composition comprising active ingredients having an effective amount of Eurycoma longifolia extract wherein the Eurycoma longifolia extract further comprising Eurycomalactone, EL30; or Eurycomalactone, EL30 in combination with 9- methoxycanthin-6-one, EL50; and/or Eurycomanone. The Eurycomalactone (EL30), 9- methoxycanthin-6-one, EL50 and Eurycomanone of the present innovation exhibit anti- ovarian cancer, breast cancer and colorectal cancer effect and potentially to be used as an anti-cancer drug candidate. The Eurycomalactone (EL30) of the present innovation is also potentially to be used as a marker compound. The anti-ovarian cancer composition of the present innovation is water soluble and less toxic.
MYUI2018702577A 2018-07-24 2018-07-24 An anti-ovarian cancer composition MY196709A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYUI2018702577A MY196709A (en) 2018-07-24 2018-07-24 An anti-ovarian cancer composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYUI2018702577A MY196709A (en) 2018-07-24 2018-07-24 An anti-ovarian cancer composition

Publications (1)

Publication Number Publication Date
MY196709A true MY196709A (en) 2023-05-02

Family

ID=87761127

Family Applications (1)

Application Number Title Priority Date Filing Date
MYUI2018702577A MY196709A (en) 2018-07-24 2018-07-24 An anti-ovarian cancer composition

Country Status (1)

Country Link
MY (1) MY196709A (en)

Similar Documents

Publication Publication Date Title
CL2019003266A1 (en) Anti-sirpalpha antibodies.
DOP2017000137A (en) BENZAMIDES SUBSTITUTED WITH 1,3-THIAZOL-2-ILO.
UY37952A (en) FORMULATIONS OF AN INHIBITOR OF THE QUINASA TRK MACROCYCLIC
CL2021001260A1 (en) Humanized anti-sirpa antibodies
EA200900046A1 (en) WEAKLY FOAMING COMPOSITIONS FOR PLANT PROTECTION
BR112016015848A2 (en) COMPOUND, COMBINATION OF A COMPOUND AND, PHARMACEUTICAL COMPOSITION
MY197901A (en) Composition containing camellia sinensis extract
AR112448A1 (en) SUBSTITUTED XANTHINE DERIVATIVES
MX2017009929A (en) Compositions and methods for improved muscle metabolism.
CL2021003228A1 (en) Tricyclic compounds and their use
MX2018004296A (en) Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist.
CA3056612A1 (en) Analogs of deutetrabenazine, their preparation and use
MY196709A (en) An anti-ovarian cancer composition
WO2019009854A3 (en) Antimicrobial compositions
EA201170269A1 (en) COMPOSITION FOR PREVENTION OR SLOWING DOWN THE DEVELOPMENT OF PROSTATE CANCER
BR112022004777A2 (en) Composition of immune-stimulating micelle
EA201590032A1 (en) LOW-TOXIC STAGGER AND METHODS OF ITS APPLICATION
ES2722098T3 (en) Adhesive compositions containing starch and uses thereof
CL2018002848A1 (en) Liquid phosphoplatin formulations
MY197711A (en) Use of compositions of water/alcohol extracts of antrodia cinnamomea cut-log wood cultivated fruiting body and solid-state cultivated mycelium as auxiliaries for anti-cancer agents
ECSP22021881A (en) AQUEOUS PHARMACEUTICAL COMPOSITION OF PROLGOLIMAB ANTI-PD1 ANTIBODY AND ITS USE
MX2022007874A (en) Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof.
PL414021A1 (en) Pharmaceutical formulation containing isocyanates and dexorubicin to be applied in treatment of tumours
MX2023003229A (en) Composition for enhanced absorption of supplements.
BR112023021489A2 (en) PHARMACEUTICAL COMPOSITION, NEAR-DRUG COMPOSITION, FOOD COMPOSITION AND USE THEREOF